Claudia Bagni Selected Research

Fragile X Syndrome (Martin Bell Syndrome)

1/2021	Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
1/2021	Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice.
11/2018	Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
1/2018	FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the FMR1 Gene.
1/2018	Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
11/2017	The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.
11/2017	Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice.
11/2017	Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.
1/2017	Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice.
12/2016	Somatosensory map expansion and altered processing of tactile inputs in a mouse model of fragile X syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Bagni Research Topics

Disease

32	Fragile X Syndrome (Martin Bell Syndrome) 01/2021 - 02/2003
21	Intellectual Disability (Idiocy) 01/2018 - 12/2002
6	Autism Spectrum Disorder 01/2020 - 10/2013
5	Neoplasms (Cancer) 01/2021 - 10/2013
5	Autistic Disorder (Autism) 01/2019 - 08/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017 - 04/2007
2	Schizophrenia (Dementia Praecox) 01/2019 - 10/2013
2	AIDS-Related Complex (ARC) 10/2017 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2013
1	Periventricular Nodular Heterotopia 01/2022
1	Atrophy 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Cholangiocarcinoma 01/2021
1	Neoplastic Processes 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 11/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Tuberous Sclerosis (Bourneville's Disease) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 07/2015
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2015
1	Mood Disorders (Mood Disorder) 10/2013
1	Triple Negative Breast Neoplasms 10/2013
1	Hepatocellular Carcinoma (Hepatoma) 10/2013
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2013
1	Disease Progression 08/2011
1	Myotonic Dystrophy (Dystrophia Myotonica) 04/2007
1	Fragile X Tremor Ataxia Syndrome 04/2007

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
17	Fragile X Mental Retardation ProteinIBA 01/2021 - 02/2003
6	Messenger RNA (mRNA)IBA 01/2021 - 04/2007
6	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 09/2005
3	5' Untranslated Regions (5' UTR)IBA 01/2018 - 12/2002
3	RNA (Ribonucleic Acid)IBA 11/2017 - 01/2013
2	BC1 RNAIBA 01/2017 - 02/2003
1	Centrosomal Associated ProteinsIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021
1	Troleandomycin (TAO)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Multiprotein ComplexesIBA 10/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2015
1	Carrier Proteins (Binding Protein)IBA 09/2015
1	Eukaryotic Initiation Factor-4EIBA 09/2015
1	Amyloid (Amyloid Fibrils)IBA 07/2015
1	VimentinIBA 10/2013
1	Cadherins (E-Cadherin)IBA 10/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2013
1	ElementsIBA 08/2011
1	Untranslated Regions (Untranslated Region)IBA 08/2011
1	gamma-Aminobutyric Acid (GABA)IBA 05/2008
1	messenger ribonucleoproteinIBA 05/2005

Therapy/Procedure

2	Therapeutics 11/2013 - 12/2012